Navigation Links
Over 60 Firms Confirmed to Attend CBI's Third Annual Bio/Pharmaceutical Collaboration and Transaction Accounting Conference in September
Date:8/27/2009

BOSTON, Aug. 27 /PRNewswire/ -- The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce their full agenda for the 3rd Annual Bio/Pharmaceutical Collaboration and Transaction Accounting. Over 60 firms are already confirmed to gather in Philadelphia on September 22nd for this one-day seminar to hear expert insights and discuss industry case examples for accounting for collaborations and transactions. Perspectives on FASB, IFRS and US GAAP, plus updates on the impact of EITF 07-1, EITF 99-19, EITF 00-21, EITF 07-3 and EITF 08-A will be presented.

The FASB and SEC are considering refinements to the collaboration accounting model. This, coupled with the trend of IFRS convergence, make it critical that life science companies master the financial accounting and reporting of deal-making activities. Amidst changing regulations, top executives from companies such as Goldman Sachs, FASB, GlaxoSmithKline, Infinity Pharmaceuticals and Johnson & Johnson will examine:

  • Recent Mergers and Acquisitions Impacting the Pharmaceutical Sector
  • Examples of Exotic Financings in Life Sciences
  • Trends in Deal Values and Economic Factors in Assessing and Valuing Innovation
  • Milestones and Revenue Arrangements with Multiple Deliverables
  • EITF Updates on Revenue Recognition and Capitalization of Milestone Payments
  • Considerations from a JFC Perspective for Joint Steering Committees (JSCs) and Other Joint Collaboration Meetings
  • FASB Accounting Guidelines for Collaborative Arrangements and Revenue Recognition

If you would like to view the full agenda, please visit this page. A "best-in-class" reputation, CPE credits and professional networking make this an extremely worthwhile event. For more information on this event, please visit http://www.cbinet.com/collaboration. If you would like to apply for a press pass, please contact Erica Kirwan of CBI at 339.298.2263.

About CBI:

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy- and decision-makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Center for Business Intelligence
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ImmuneRegen BioSciences Confirms Homsperas Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration
2. Independent Study Confirms Superior Properties of ZPC(TM) Enhanced Calcium Composite Bone Grafts
3. Independent U.S. Study Confirms Veritides Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability
4. Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize
5. Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
6. NIH News Confirms Trend in Stem Cell Storage Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
7. GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling
8. Mylan Confirms Four First-to-File Challenges
9. Gentag, Inc. Engages US and UK Firms to Explore Strategic Options
10. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
11. Amylin Pharmaceuticals Confirms Receipt of Director Nomination Notices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... ... ... Back pain relief technology is now available without a prescription at What ... relief for WAR members. , This spinal restoration platform boasts utilization of technology that ... suffering from chronic back pain. , What A Relief Back Pain Centers ...
(Date:1/11/2017)... , PITTSBURGH and BENGALURU, ... (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, ... Drug Administration (FDA) has accepted Mylan,s biologics license application ... through the 351(k) pathway. This product is a proposed ... certain HER2-positive breast cancers. The anticipated FDA goal date ...
(Date:1/11/2017)... , Jan. 11, 2017  GenVec, Inc. ... delivery company, announced today that its chief scientific ... a talk entitled  "AdenoVerse™ platform for translational development ... Biotech Showcase at the upcoming Phacilitate Cell & ... Miami , Florida.  Dr. Brough,s presentation will ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... signed a multi-year license agreement with Poseida Therapeutics Inc, the San Diego based ... genetic data. Poseida Therapeutics selected KBioBox in order to harness KBioBox’s powerful BioEngine ...
Breaking Biology Technology:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):